Piper Sandler Sticks to Their Buy Rating for CVS Health (CVS)
Piper Sandler analyst Jessica Tassan maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $64.00. The ...
CVS Health price target lowered to $64 from $72 at Piper Sandler
Piper Sandler lowered the firm’s price target on CVS Health (CVS) to $64 from $72 and keeps an Overweight rating on the shares. The firm ...